Trial Details
COMPLETEDBasic Information
| Clinical ID | c3454 |
|---|---|
| Identifier | NCT02039063 |
| Trial Title | A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: E6011 2 mg/kg|DRUG: E6011 5 mg/kg|DRUG: E6011 10 mg/kg|DRUG: E6011 15 mg/kg |
Participant Information
| Sponsor | EA Pharma Co., Ltd. |
|---|---|
| City | Aichi-ken |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2014-04-05 |
|---|---|
| Primary Completion Date | 2017-01-06 |
| Completion Date | 2017-11-27 |